Teva Pharmaceuticals Settles New York Opioid Litigation For $313M Over 18 Years
NEW YORK — New York’s attorney general on Nov. 3 announced that opioid defendant Teva Pharmaceuticals Ltd. and affiliates have agreed to pay $313.34 million over 18 years to settle state...To view the full article, register now.
Already a subscriber? Click here to view full article